Equity · Healthcare
DXCM
DexCom, Inc. · NasdaqGS
The line runs $69.72 on 24 June through $86.43 on 15 September, on a scale from $60 to $100. Days the market did not trade hold the previous close, flat.
The chart above plots the price of DXCM over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 58 sessions over that window: $69.72 on 24 June 2026 through $86.43 on 15 September 2026.
Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Sep 21, 2026
DXCM insider trades
Showing the 12 most recent of 13 open-market trades in this window. The figures above count all of them.
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
DXCM reported financials
DXCM reported revenue of $4.7B for the fiscal year ended 31 Dec 2025. Net income over the same period was $836.3M.
Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
DXCM earnings
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
DXCM institutional holders
12 of the 45 institutional funds we track reported a DXCM position for the quarter ended 30 Jun 2026 — a combined $555.8M; the latest of those filings landed 02 Sep 2026.
Showing the 10 largest of 12 reported positions. The figures above count all of them.
Source: SEC EDGAR 13F filings
DXCM fails-to-deliver
On 28 Aug 2026, 3,579 shares of DXCM failed to deliver (about $320K).
Source: SEC fails-to-deliver (CNS) data